Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023)

Journey Medical filings provide 4 years of Other Non-Current Liabilities readings, the most recent being $1.5 million for Q2 2023.

  • On a quarterly basis, Other Non-Current Liabilities fell 60.87% to $1.5 million in Q2 2023 year-over-year; TTM through Jun 2023 was $1.5 million, a 60.87% decrease, with the full-year FY2022 number at $1.4 million, down 61.07% from a year prior.
  • Other Non-Current Liabilities hit $1.5 million in Q2 2023 for Journey Medical, up from $1.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $8.1 million in Q4 2020 to a low of $1.4 million in Q3 2022.
  • Median Other Non-Current Liabilities over the past 4 years was $3.5 million (2021), compared with a mean of $3.2 million.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 55.43% in 2021 and later plummeted 61.18% in 2022.
  • Journey Medical's Other Non-Current Liabilities stood at $8.1 million in 2020, then tumbled by 55.43% to $3.6 million in 2021, then plummeted by 61.07% to $1.4 million in 2022, then increased by 5.52% to $1.5 million in 2023.
  • The last three reported values for Other Non-Current Liabilities were $1.5 million (Q2 2023), $1.4 million (Q1 2023), and $1.4 million (Q4 2022) per Business Quant data.